Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion

Review proposal consultation

Stakeholder matrix (PDF 255 KB)

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: equality impact assessment - guidance review

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination information

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document (PDF 364 KB)

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: evaluation report information

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection (1st line): equality impact assessment - scoping

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection (1st line): response to consultee and commentator comments on the draft scope and provisional matrix

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection (1st line): final matrix

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection (1st line): final scope

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: draft scope - (pre referral)

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: provisional matrix - (pre referral)